Paradigm Biocapital Advisors LP MLTX Holdings History
Paradigm Biocapital Advisors LP's MoonLake Immunotherapeutics Holding Summary
As of 2025-03-31, Paradigm Biocapital Advisors LP held 627,423.00 shares of MoonLake Immunotherapeutics(MLTX), totaling $24.51 Mil. This investment constitutes 1.12% of their stock portfolio, and Paradigm Biocapital Advisors LP now holds 0.99% of the outstanding MoonLake Immunotherapeutics(MLTX) stock.
The initial trade took place in 2023Q2. And since then Paradigm Biocapital Advisors LP has made 3 purchases of MLTX, at an average price of $45.05, for a total of 2.14 Mil shares. In addition, there have been 2 sales at an average price of $46.05 for 1.51 Mil shares. Based on historical transaction data and MLTX's current price of $49.00, Paradigm Biocapital Advisors LP's estimated gain on his MLTX holdings is $4.00 Mil, reflecting a 4.14% gain to date.
Paradigm Biocapital Advisors LP MLTX ($49.00) Holding Chart
Paradigm Biocapital Advisors LP MLTX ($49.00) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
